The availability of animal systems representative of various pulmonary hypersensitivity reactions in man would be useful in several areas of study. Such animal models of respiratory disease resulting from immune mechanisms could be classified in several ways. One approach is to categorize the reaction by the major type of immune reaction involved. These include responses due to immediate type (wheal and erythema, reaginic) hypersensitivity, responses presumed due to precipitating type of antibodies, and responses due to delayed (cellular) hypersensitivity. Other possible reactions could result from antigen-antibody complexes or from autoimmune reactions due to antibody directed against pulmonary tissue. Finally, reactions could result from combinations of two or more of the above types of immune substances directed against the same antigen.
Pulmonary reactions resulting from the reaginic of antibody are common clinical phenomena and are reproducible under experimental conditions. These reactions will be described in detail. Reactions from precipitating antibody almost certainly occur and presumably account for certain types of infiltrative lung disease. The same type of antibodies in the presence of excess antigen would form soluble antigen-antibody complexes and it is not unlikely that these complexes may play a role in certain types of infiltrative lung disease. Delayed hypersentivity as a mechanism of production of chronic pulmonary disease is even less well defined. Hypersensitivity of this type to inhaled organic or inorganic material or to microbial antigens may be related to various pulmonary reactions.
In a second approach, the type of model desired might be classified by the type of pulmonary disease it is expected to simulate. Acute or chronic reversible airway obstructive changes analogous, to some extent, to human asthma can be produced. There has been no evidence arising from clinical or experimental studies which demonstrates that the chronic irreversible lung disease termed pulmonary emphysema is the result of a hypersensitivity reaction to any of the immunologic mechanisms described above. Until the etiology of the irreversible airway disease is established, the possibility that immunologic mechanisms may play a primary or contributing factor is not excluded.
Finally, the third type of approach to establishment of animal systems could be directed toward the reproduction of those pathological or physiologic changes that have been described in pulmonary disease proven or presumed to be due to immune mechanisms. Whether or not the primary direction is toward reproduction of histologic changes, those tissue changes occurring in the human disease state should be observed in animal disease simulating its counterpart in man. The remainder of this report concerns animal systems developed for study of reaginic allergy.
ANIMAL MODELS OF ACUTE RESPIRATORY RESPONSES TO ANTIGENS
For several years, work in our laboratory has involved the study of immediate type hypersensitivity disease as it occurs spontaneously in man and animals in response to environmental antigens. These studies have included observations on the comparative immunology of reaginic antibody,1 characterization of certain antigens2 and reactions of these antigens with reaginic antibodies,3 mediator release from leukocytes as a result of reaginic antibody and antigen interaction,' and certain factors affecting such immunologically mediated histamine release.! One major direction of study has been the description of the biologic results of in vivo reactions of reaginic antibody with specific antigens (more completely reviewed elsewhere).' The present report describes one area of these studies and application of these studies to the production of acute models of respiratory reactions. The type of respiratory response under study is not considered to be one responsible for the production of chronic irreversible obstructive lung disease in man. The acute respiratory response is thought to be representative of acute, antibody-mediated reactions of the respiratory tract which are analogous to certain hypersensitivity reactions of the human respiratory tract. In man, this type of reaction may produce chronic, reversible, obstructive airway disease.
We have developed three systems of airway response that produce demonstrable alterations in respiratory physiology. Each system will be described briefly and will be discussed in terms of its reproducibility, availability, the characterization of its immunologic aspects, problems in application, and limitations in utilization.
Canine reaginic allergy
Immediate type reactivity to pollen and other environmental antigens occurs in dogs. The spontaneous allergic disease in dogs is characterized clinically by the seasonal occurrence of dermatitis, rhinitis, conjunctivitis, or asthma.
There are similarities and differences between the seasonal allergic disease in dog and man. Similarities include the type of antigens responsible for the reactions and the immunologic basis for the disease. One major difference is the high incidence of seasonal dermatitis in dogs while the allergic reaction in man is primarily in the respiratory tract. The environmental etiologic factors in human seasonal allergic respiratory disease are relatively easily defined. Etiologic factors in dogs in all cases of seasonal dermatitis, with the exception of ragweed pollinosis, are more difficult to determine, and some of these cases of seasonal dermatitis may not be hypersensitivity reactions. The reaginic antibody in dogs with proven ragweed pollinosis has been characterized by most methods applied to the study of human reaginic antibody, and the physico-chemical properties of the canine reagin are similar to those of human reagin.16 Characterization of the canine reagin has been limited by lack of availability of preparations of pure canine immunoglobulins and the monospecific antisera which can be prepared against such purified preparations. Preliminary studies have led us to suggest that canine reaginic antibody against environmental antigens is located in a canine immunoglobulin type that is analogous to IgE of man. 7 The degree of hypersensitivity of an allergic dog may be demonstrated by transfer of cutaneous reactivity to the skin of normal dogs by dilutions of the reaginic serum. When a dog with a sufficient degree of hypersensitivity to ragweed is challenged by means of an aerosol of ragweed antigen, symptoms of acute dyspnea occur and provide a canine model of acute respiratory reaction to inhaled antigen. The bronchial response is reproducible and has been observed under controlled conditions in five dogs with ragweed sensitivity. The bronchial reactivity appears persistent since it has been repeatedly demonstrated in one dog over a period of nine years. Physiologic measurements and quantitative antigenic challenge are possible but not easily accomplished in the unanesthetized allergic dog. Antigenic challenge by aerosolized antigen following administration of anesthesia given to prepare the subject for physiologic measurements and controlled aerosol challenge may result in sudden death. The animals avail-able are limited in number and all dogs with reaginic antibody may not react with a bronchial response. It is possible that this difference in bronchial response in ragweed sensitive dogs may be the result of inherited or acquired variations in the sensitivity of the respiratory tract not mediated by immunologic mechanisms. However, the only correlation that has appeared in the limited studies possible is the smaller amount of circulating reaginic antibody in those dogs not responding to aerosol challenge with specific antigen.
The number of allergic dogs available for repeated studies is small. While canine reaginic allergy is not rare,8 few animals are made available for laboratory study. Current attempts by our research unit to develop inbred strains of dogs with the tendency to develop reaginic disease are in progress, but development of this project has been limited by the availability of breeding stock and by the availability of methods of assessment of the development of the desired sensitivity.
A related canine reaginic system more immediately available is dependant upon the passive sensitization of normal dogs with canine reaginic antisera. The intravenous administration of an appropriate amount of reaginic serum containing a sufficient antibody titer results in transient systemic sensitivity of the recipient dog. Following the passive sensitization, the recipient animal has cutaneous, anaphylactic or bronchial reactivity depending on the route of antigenic challenge. When such a dog is anesthetized and challenged under controlled conditions by administration of aerosolized antigen, alterations in pulmonary physiology are detectable. The measureable changes include alterations in breathing frequency, tidal volume, maximal expiratory flow rate and ratios of expiratory to inspiratory periods. The findings are considered consistent with the production of acute, reversible obstructive airway changes. The system has been reproducible in the same or different recipients. There are two major limitations in use of the passively sensitized dog system. These include the desensitization that follows sufficient exposure to antigen in an experiment that requires repeated sensitization for subsequent experiments, and the lack of availability of large amounts of high titered canine reaginic sera.
Passive sensitization of sub-human prinwtes with human reaginic sera Rhesus and other monkeys can be passively sensitized locally or systemically with human reaginic sera. Intravenous challenge following systemic sensitization of the monkeys results in anaphylaxis during which the clinical manifestations are similar to those of man. The physiologic and histologic abnormalities occurring during and after monkey anaphylaxis have been described.9"10 When the rhesus monkeys, passively sensitized with human reaginic serum, are challenged with specific antigen by aerosol, alterations in respiratory function similar to those in the dog system occur. These respiratory function changes are measured during antigenic challenge in the anesthetized state and consist of increased breathing frequency, a decrease in tidal volume and maximal expiratory flow rate. In some animals, prolongation of the expiratory phase of respiration was observed. During severe respiratory responses in which blood gas concentrations were determined, there were decreases in arterial oxygen and increases in arterial carbon dioxide concentrations. The results of these experiments were consistent with the occurrence of acute obstructive reversible airflow obstruction as a result of the reaction of antigen and reaginic antibody in the bronchial mucosa. The histopathology of such sites have not been studied. The system is reproducible provided that there is appropriate selection of human donor and provided the recipient is tested by local cutaneous sensitization and shown to be a suitable recipient for sensitization by human reaginic antibody. A limitation of the system is the desensitization of the sensitized monkey by exposure of the animal to antigen. This requires repeated sensitization for a second experiment. There is a limited number of times an animal can be used for passive sensitization, because the human sera results in active sensitization of the monkey. The development of antibodies by the monkey against human reagin inhibits subsequent passive sensitization with human serum.
Active reaginic sensitivity of the monkey
The ideal model of reaginic sensitivity for laboratory study would be extrinsic sensitivity of the monkey to inhaled environmental antigens.
While it may be predicted that such reactivity exists, it has not yet been described. We have studied the occurrence of immediate reactivity of rhesus monkeys to ascaris antigen and found a significant incidence of ascaris sensitivity among an unselected population of monkeys.1' The monkeys demonstrating a sufficient degree of ascaris sensitivity react with cutaneous, anaphylactic, and bronchial reactivity to specific challenge with ascaris antigen. The particular clinical response depends on whether the antigenic challenge is given by the cutaneous, intravenous, or bronchial route. The initial studies of bronchial reactivity of these monkeys demonstrate a reproducible airway response with all characteristics of the other two (dog and monkey) systems.1' These monkeys characteristically develop expiratory rales and wheezes during the acute phase of respiratory response. The reactivity has been shown to be related to a serum antibody that is thermolabile, non-precipitable, skin-sensitizing and localized between the first two peaks of a Sephadex G-200 chromatographic preparation. The antibody against ascaris thus has many of the characteristics of human reaginic antibody. Limitations of the system are lack of characterization and purification of ascaris antigens. The possibility that a component of certain of the reactions is due to nonimmunologic chemically mediated reactions has not been excluded. In spite of this, the ascaris model of bronchial reactivity probably has the most potential for study of respiratory responses because of its availability and reproducibility in the same subject.
SUMMARY
Three systems of reproducible airway obstructive changes occurring as a result of specific reaginic antibody-antigen reactions are described. These systems produce measurable physiologic alterations in experimental subjects under controlled conditions. They provide a system for study of acute respiratory failure and for the study of changes that occur in certain chronic respiratory obstructive diseases.
